Dr Preethi Gunaratne

preethi

University of Houston

Preethi Gunaratne, assistant professor in the department of biology and biochemistry, is studying a class of tiny genetic molecules known as microRNAs and pinpointing those that could unleash the body’s natural cancer-fighting agents. Additionally, she is developing a novel method to effectively deliver this treatment to the targeted cells by using an unusual carrier – nanoparticles of gold – through the work of Lalithya Jayarathne, a postdoctoral researcher in Gunaratne’s lab. 

Gunaratne’s potentially groundbreaking work in ovarian cancer has gained exceptional notice and momentum this year with a series of high-profile research grants. In October, her ovarian cancer project was awarded a $200,000 High Impact/High Risk grant from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state’s billion-dollar war on cancer. In November, she was approved for a $250,000 grant from Houston’s Cullen Foundation. Earlier this year, she was chosen a beneficiary of the Baylor College of Medicine Partnership Fund. 

Organising Committee

Michelle Haber (Chair)   
Kiri Collins
Tony Phillips    
Maria Kavallaris
Carol Wadham    
Liz Wynn    
David Ziegler    
Greg Arndt
Jessica Keath
Murray Norris
Amanda Philp
Peter Wejbora
Denise Yu
Maree Overall (ASN Events)

Program Committee

Maria Kavallaris (Chair)
Michelle Haber
Richard Lock
Glenn Marshall
Amanda Philp
Toby Trahair   
David Ziegler
Jenny Byrne (SCHN)
Phil Hogg (UNSW)
Debbie Marsh (USYD)
Clare Scott (WEHI)
Alex Swarbrick (Garvan)   
Nikki Verrills (HMRI/UON)
Jamie Fletcher
Tao Liu
Karen MacKenzie
Murray Norris
Rosemary Sutton
Peter Wejbora
Tracy Bryan (CMRI)
Peter Gunning (UNSW)
Lisa Horvath (Lighthouse)
Grant McArthur (Peter Mac)
Ian Street (WEHI)
Mathew Vadas (Centenary)
Maree Overall (ASN)